- Home
- STBA vs IMTX Comparison
STBA vs IMTX Comparison
Compare STBA & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STBA | IMTX |
|---|---|---|
| Founded | 1902 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | STBA | IMTX |
|---|---|---|
| Price | $39.47 | $10.80 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $41.25 | $19.25 |
| AVG Volume (30 Days) | 213.1K | ★ 640.0K |
| Earning Date | 10-23-2025 | 11-17-2025 |
| Dividend Yield | ★ 3.65% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.46 | N/A |
| Revenue | ★ $391,893,000.00 | $99,445,031.00 |
| Revenue This Year | $7.40 | N/A |
| Revenue Next Year | $4.94 | $13.52 |
| P/E Ratio | $11.41 | ★ N/A |
| Revenue Growth | ★ 1.21 | N/A |
| 52 Week Low | $30.84 | $3.30 |
| 52 Week High | $43.69 | $11.25 |
Technical Indicators
Market Signals| Indicator | STBA | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.73 | 57.57 |
| Support Level | $36.95 | $9.84 |
| Resistance Level | $40.90 | $11.34 |
| Average True Range (ATR) | 1.11 | 0.78 |
| MACD | 0.16 | 0.07 |
| Stochastic Oscillator | 64.85 | 78.93 |
Price Performance
Historical ComparisonAbout STBA S&T Bancorp Inc.
S&T Bancorp Inc is a bank holding company. The company operates in five markets including Western Pennsylvania, Eastern Pennsylvania, Northeast Ohio, Central Ohio and Upstate New York. The company provides financial services with retail and commercial banking products, cash management services, trust and brokerage services. It operates only in one segment which is Community Banking. The company earns revenue from interest on loans and securities and fees charged for financial services provided to its customers.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.